GSK Hails Success For Novel Antibiotic – But Reaching $1bn Sales Will Be A Challenge
Company Expects To File In H1 2023
GSK is returning to its long heritage in antibiotics with a potential first-in-class drug that has just shown promise in urinary tract infection; hopes are that it can reach annual sales of $1bn.
